Manufacturer
Sun Pharmaceutical Industries Ltd.
Contents
Gemcitabine
Indication
Cancer, pancreatic/ Breast cancer/ Bladder cancer/ Non-small cell lung cancer/ Ovarian cancer
Instruction
Administered by a healthcare provider into the vein.
Drug interaction
May cause pulmonary toxicity w/ concurrent use of bleomycin. May enhance anticoagulant effect of warfarin.Potentially Fatal: Admin of yellow fever and other live attenuated vaccines may increase risk of systemic disease esp in immunosuppressed patients.